SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at BIO InvestorForum 2007 on Wednesday, October 10, 2007, at 12:15 p.m. Pacific Time at The Palace Hotel in San Francisco.
